Examine the Rheumatoid Arthritis Drug Pipeline With New Report
Posted on: Monday, 16 July 2007, 09:13 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c62858) has announced the addition of "Autoimmune and Inflammation - Rheumatoid Arthritis Drug Pipeline Report" to their offering.
"Autoimmune and Inflammation - Rheumatoid Arthritis Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of rheumatoid arthritis drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
Keep track of your competitors and partners by better understanding their product pipeline.
Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
Maintain a critical competitive advantage.
RECENT HIGHLIGHTS AND CHANGES
Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Rheumatoid Arthritis Pipeline Overview
% of Projects (By Phase of Development)
No. of Projects by Phase of Development
Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
Company Overview - Pipeline Projects
Legend
Top 20 companies in late stage Rheumatoid Arthritis Projects
Top 20 companies in early stage Rheumatoid Arthritis Projects
Full Pipeline View
Pre Clinical Pipeline View
Phase I Pipeline View
Phase II Pipeline View
Phase III Pipeline View
Pending Approval Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c62858
Source: Life Science Analytics
Source: Business Wire
Related Articles
- Waterfall Security Solutions Announces new Product Release: Waterfall(R) Remote Screen View(TM)
- Lockheed Martin SBIRS Team Advancing to Follow-on Production Phase
- University of Maryland Announces 17 Research Projects Involving Faculty, Maryland Companies to Develop New Commercial Products
- Alvine Pharmaceuticals Reports Positive Results With ALV003 in Phase 1 Trial of Therapy in Development for Celiac Disease
- Evaluate Therapies Under Development for Peripheral Artery Disease With This Detailed Clinical and Commercial Assessment
- PSTS China to Commence Production Expansion Project
- Medistem Laboratories Announces Plan for Angiostem(TM) to Be First Pipeline Product for U.S. Commercialization
- Clinical Data on Pharmion's Marketed and Pipeline Products to Be Presented at the American Society of Clinical Oncology 42nd Annual Meeting
- FMC Technologies Awarded Subsea Systems Contract for Statoil Vigdis Extension Phase 2 Project
- NASA Selects Small Business Technology Transfer Phase 2 Projects
 |
 |
User Comments (0)
RSS Feeds